Showing results (21-30 of 171) with videos related to
Sort By:
Pageof 18
Methods in Enzymology|January 1, 1995
Mammalian glycosylphosphatidylinositol-anchored proteins and intracellular precursorsS Hirose, J J Knez, M E MedofJournal of Immunology (Baltimore, Md. : 1950)|December 1, 1990
The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factorC Mold, E I Walter, M E MedofHuman Genetics|June 1, 1995
Identification of a PIG-A related processed gene on chromosome 12S Nagarajan, C J Brown, M E MedofOptometry and Vision Science : Official Publication of the American Academy of Optometry|January 4, 2001
Decay-accelerating factor in tears of contact lens wearers and patients with contact lens-associated complicationsL B Szczotka, E Cocuzzi, M E MedofBrazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|February 1, 1994
Metabolism of GPIs in mammalian cellsT L Rosenberry, D Sevlever, M E MedofProceedings of the National Academy of Sciences of the United States of America|August 1, 1982
Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of Beta 1H and is accompanied by generation of C3cM E Medof, G M Prince, C MoldAnnals of Neurology|April 1, 1979
Suppressor cell function in multiple sclerosis: correlation with clinical disease activityJ P Antel, B G Arnason, M E MedofThe Journal of Experimental Medicine|July 1, 1985
Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuriaT Kinoshita, M E Medof, R Silber, et al.The Journal of Experimental Medicine|December 1, 1982
Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexesM E Medof, K Iida, C Mold, et al.Immunopharmacology|July 17, 1999
Decay acceleration of the complement alternative pathway C3 convertaseD E Hourcade, L M Mitchell, M E MedofPageof 18